{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:12:57Z","timestamp":1792141977784,"version":"4.4.0"},"reference-count":78,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2025,1,2]]},"DOI":"10.1080\/17474086.2025.2449863","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T08:36:39Z","timestamp":1735979799000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Radioimmunotherapy of acute myeloid leukemia: a critical assessment of its prospects and limitations"],"prefix":"10.1080","volume":"18","author":[{"given":"Donald","family":"Bunjes","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01230-4"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013626"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2012.150"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.6499"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129204"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2007.06.029"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.145"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.1460"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2014.0123"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.7091"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30022-X"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190412331283206"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.4.576"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-364265"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.9.1867.1867"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.11.3960a"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705182"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2060735"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.08.035"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0797-730"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1080"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.03.025"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280800"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.775128"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature22993"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0044-0"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091358"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2020.01.004"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113087"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051174"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2015.12.043"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2015.07.003"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01580-7"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63557-9"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2008.05.002"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2020.07.002"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2015.00012"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90336-3"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-4021-5_21"},{"issue":"8","key":"e_1_3_5_43_1","first-page":"1337","article-title":"Implications of nonuniform tumor doses for radioimmunotherapy","volume":"40","author":"O\u2019Donoghue JA","year":"1999","unstructured":"O\u2019Donoghue JA. Implications of nonuniform tumor doses for radioimmunotherapy. J Nucl Med. 1999;40(8):1337\u20131341.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/rpd\/31.1-4.433"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.2307\/3578453"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057398"},{"issue":"3","key":"e_1_3_5_47_1","first-page":"521","article-title":"Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides","volume":"35","author":"Goddu SM","year":"1994","unstructured":"Goddu SM, Rao DV, Howell RW. Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. J Nucl Med. 1994;35(3):521\u2013530.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/41\/10\/009"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1003908"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2021.11.005"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-79952-5_2"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1216-z"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.4.1122.bloodjournal8541122"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704201"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.4.1237"},{"issue":"8","key":"e_1_3_5_56_1","first-page":"1335","article-title":"Anti-CD45 monoclonal antibody YAML568: a promising radioimmunoconjugate for targeted therapy of acute leukemia","volume":"47","author":"Glaring G","year":"2006","unstructured":"Glaring G, M\u00fcller M, Koop B, et al. Anti-CD45 monoclonal antibody YAML568: a promising radioimmunoconjugate for targeted therapy of acute leukemia. J Nucl Med. 2006;47(8):1335\u20131341.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-213298"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.05.014"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.229492"},{"issue":"3","key":"e_1_3_5_60_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2666-6367(21)00083-X","article-title":"A phase I trial first-in-human alpha-emitter astatine-211-labeled anti-CD45 antibody (211-At-BC8-B10) in combination with fludarabine and TBI as conditioning for allogeneic hematopoietic cell transplantation for patients with refractory\/relapsed leukemia or high-risk myelodysplastic syndrome (mds): preliminary results of dose escalation","volume":"27","author":"Sandmaier B","year":"2021","unstructured":"Sandmaier B, Wilbur DS, Hamlin DK, et al. A phase I trial first-in-human alpha-emitter astatine-211-labeled anti-CD45 antibody (211-At-BC8-B10) in combination with fludarabine and TBI as conditioning for allogeneic hematopoietic cell transplantation for patients with refractory\/relapsed leukemia or high-risk myelodysplastic syndrome (mds): preliminary results of dose escalation. Transpl Cell Ther. 2021;27(Supplement 3):64.","journal-title":"Transpl Cell Ther"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-187433"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-182177"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-189040"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.21397"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.06.256"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.768.768"},{"issue":"1","key":"e_1_3_5_67_1","first-page":"2638","article-title":"A phase 2 study of actinium -225(225Ac) - lintuzumab in older patients with previously untreated acute myeloid leukemia (AML) unfit for intensive chemotherapy","volume":"130","author":"Finn L","year":"2017","unstructured":"Finn L, Levy M, Orozco JJ, et al. A phase 2 study of actinium -225(225Ac) - lintuzumab in older patients with previously untreated acute myeloid leukemia (AML) unfit for intensive chemotherapy. Blood. 2017;130(Supplement 1):2638.","journal-title":"Blood"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3665"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2317"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.3.565"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-284349"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143660"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05663.x"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02317-z"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00509-w"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1011"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116132"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.085589"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.073155"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01241"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2025.2449863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T04:11:44Z","timestamp":1737000704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2025.2449863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"alternative-id":["10.1080\/17474086.2025.2449863"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2025.2449863","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}